[Form 4] Enovix Corp Insider Trading Activity

Rhea-AI Filing Summary

Enovix Corp (ENVX) reported an insider equity transaction by its Chief Accounting Officer, Kristina Truong. On November 13, 2025, 1,013 shares of common stock were withheld at a price of $8.08 to cover tax obligations related to the vesting of restricted stock units (RSUs). After this transaction, the reporting person beneficially owned 198,502 shares of common stock.

This total includes 155,474 shares issuable upon vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs). For these PRSUs, 50% of the shares are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027, with each RSU or PRSU representing the right to receive one share of Enovix common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Truong Kristina

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,013	$8.08	$8K

Holdings After Transaction: Common Stock — 198,502 shares (Direct)

Footnotes (1)

1. Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on November 13, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Includes 155,474 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person and 4,978 shares of vested performance RSUs ("PRSUs"), of which 50% will be released in on March 2, 2026 and the remaining 50% will be released on March 1, 2027. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Truong Kristina

(Last) (First) (Middle)

3501 W WARREN AVENUE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		F		1,013(1)	D	$8.08	198,502(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on November 13, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

2. Includes 155,474 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person and 4,978 shares of vested performance RSUs ("PRSUs"), of which 50% will be released in on March 2, 2026 and the remaining 50% will be released on March 1, 2027. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.

Remarks:

	/s/ Arthi Chakravarthy, Attorney-in-Fact for Kristina Truong	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Enovix (ENVX) report in this Form 4?

The filing reports that the Chief Accounting Officer had 1,013 shares of Enovix common stock withheld on November 13, 2025 to satisfy tax withholding obligations upon the vesting of RSUs, at a price of $8.08 per share.

How many Enovix (ENVX) shares does the reporting person beneficially own after the transaction?

Following the reported transaction, the officer beneficially owns 198,502 shares of Enovix common stock, including shares underlying unvested RSUs and vested PRSUs.

What RSU and PRSU awards are included in the Enovix (ENVX) Form 4 filing?

The position includes 155,474 shares issuable upon the vesting and settlement of RSUs and 4,978 vested performance RSUs (PRSUs), with each unit representing a right to receive one share of Enovix common stock.

When will the Enovix (ENVX) performance RSUs reported in this Form 4 be released?

For the 4,978 vested PRSUs, 50% of the shares are scheduled to be released on March 2, 2026 and the remaining 50% on March 1, 2027.

Why were Enovix (ENVX) shares withheld in the reported Form 4 transaction?

The 1,013 shares were withheld to satisfy tax withholding obligations that arose when restricted stock units vested on November 13, 2025.

Who is the reporting person in this Enovix (ENVX) Form 4 filing and what is their role?

The reporting person is an officer of Enovix serving as Chief Accounting Officer, as indicated in the filing.